Nanocan Therapeutics

United States
Hastings, Minnesota, United States, 08540

Company profile

Nanocan Therapeutics company profile

Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections. The company leverages nanotechnology to create solutions for hard-to-cure indications where current interventions are insufficient. Through the application of nanotechnology to medicine, Nanocan aims to help improve the quality of life of our patients, increase access to medicine and other treatments, and to reduce global health disparities.

Business identity

Phone number
202-258-1591
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-01-01, Year

Headquarters

Postal code
08540
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.1M
Last funding
Seed / $1.1M / 2020-08-24
Last equity funding
Seed / $1.1M
Founders
2

Founders and investors

Founders

Eric BroylesJacques P. Walker